| Primary |
| Product Used For Unknown Indication |
15.7% |
| Drug Use For Unknown Indication |
9.3% |
| Breast Cancer Metastatic |
7.4% |
| Antiplatelet Therapy |
5.6% |
| Non-hodgkin's Lymphoma |
5.6% |
| Type 2 Diabetes Mellitus |
5.6% |
| Diarrhoea |
4.6% |
| Hypertension |
4.6% |
| Pain |
4.6% |
| Parkinson's Disease |
4.6% |
| Abdominal Pain Upper |
3.7% |
| Anxiety |
3.7% |
| Hepatitis C |
3.7% |
| Infection |
3.7% |
| Ocular Hypertension |
3.7% |
| Acute Myeloid Leukaemia |
2.8% |
| Acute Myocardial Infarction |
2.8% |
| Lentivirus Test Positive |
2.8% |
| Liver Transplant |
2.8% |
| Non-small Cell Lung Cancer |
2.8% |
|
| Pneumonia |
12.1% |
| Product Quality Issue |
12.1% |
| Thrombosis In Device |
9.1% |
| Vomiting |
9.1% |
| Death |
6.1% |
| Pulmonary Embolism |
6.1% |
| Toxicity To Various Agents |
6.1% |
| Acute Generalised Exanthematous Pustulosis |
3.0% |
| Anaemia Haemolytic Autoimmune |
3.0% |
| Anterior Chamber Cell |
3.0% |
| Anterior Chamber Flare |
3.0% |
| Appendicitis |
3.0% |
| Application Site Burn |
3.0% |
| Bladder Tamponade |
3.0% |
| Brain Stem Infarction |
3.0% |
| Cardiac Failure Congestive |
3.0% |
| Chest Discomfort |
3.0% |
| Chest Pain |
3.0% |
| Epilepsy |
3.0% |
| Febrile Neutropenia |
3.0% |
|
| Secondary |
| Product Used For Unknown Indication |
35.3% |
| Parkinson's Disease |
8.8% |
| Hepatitis C |
6.7% |
| Rheumatoid Arthritis |
5.6% |
| Hypertension |
5.2% |
| Diabetes Mellitus |
4.0% |
| Prophylaxis |
3.8% |
| Acute Lymphocytic Leukaemia |
3.6% |
| Type 2 Diabetes Mellitus |
3.3% |
| Insomnia |
2.7% |
| Crohn's Disease |
2.7% |
| Pain |
2.3% |
| Constipation |
2.3% |
| Osteoporosis Postmenopausal |
2.3% |
| Drug Use For Unknown Indication |
2.2% |
| Musculoskeletal Pain |
2.0% |
| Percutaneous Coronary Intervention |
1.9% |
| Angina Pectoris |
1.8% |
| Myocardial Infarction |
1.8% |
| Neuroblastoma |
1.7% |
|
| Somatic Hallucination |
14.7% |
| Vomiting |
10.8% |
| Toxicity To Various Agents |
7.8% |
| Rash |
5.9% |
| Weight Decreased |
5.9% |
| Weight Increased |
4.9% |
| Wrong Technique In Drug Usage Process |
4.9% |
| Renal Failure Acute |
4.4% |
| Completed Suicide |
3.9% |
| Pneumonia |
3.9% |
| Swelling Face |
3.9% |
| Thrombocytopenia |
3.9% |
| Urticaria |
3.9% |
| White Blood Cell Count Decreased |
3.9% |
| Drug Hypersensitivity |
2.9% |
| Infection |
2.9% |
| Pyrexia |
2.9% |
| Respiratory Arrest |
2.9% |
| Visual Impairment |
2.9% |
| Drug Dispensing Error |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.1% |
| Crohn's Disease |
5.4% |
| Hepatitis C |
5.4% |
| Hypertension |
5.4% |
| Depression |
4.6% |
| Hypothyroidism |
4.6% |
| Drug Use For Unknown Indication |
4.2% |
| Breast Cancer |
3.8% |
| Bipolar Disorder |
3.3% |
| Constipation |
3.3% |
| Post-traumatic Stress Disorder |
3.3% |
| Prophylaxis |
3.3% |
| Asthma |
2.9% |
| Psoriasis |
2.9% |
| Anxiety |
2.5% |
| Blood Cholesterol Increased |
2.5% |
| Gastrooesophageal Reflux Disease |
2.5% |
| Sleep Disorder |
2.5% |
| Hypersensitivity |
2.1% |
| Large Cell Carcinoma Of The Respiratory Tract Stage Unspecified |
2.1% |
|
| Somnolence |
9.8% |
| Urticaria |
7.8% |
| Drug Ineffective |
5.9% |
| Inappropriate Schedule Of Drug Administration |
5.9% |
| Off Label Use |
5.9% |
| Pain |
5.9% |
| Pruritus |
5.9% |
| Weight Increased |
5.9% |
| Blood Pressure Increased |
3.9% |
| Febrile Neutropenia |
3.9% |
| Flushing |
3.9% |
| Loss Of Consciousness |
3.9% |
| Nausea |
3.9% |
| Plasma Cell Myeloma |
3.9% |
| Post Procedural Infection |
3.9% |
| Product Quality Issue |
3.9% |
| Pyrexia |
3.9% |
| Rhinorrhoea |
3.9% |
| Sepsis |
3.9% |
| Toxicity To Various Agents |
3.9% |
|
| Interacting |
| Product Used For Unknown Indication |
23.5% |
| Hypertension |
11.1% |
| Complex Partial Seizures |
8.6% |
| Antiplatelet Therapy |
7.4% |
| Pain |
7.4% |
| Gastritis |
4.9% |
| Affective Disorder |
3.7% |
| Convulsion |
3.7% |
| Gastritis Erosive |
3.7% |
| Insomnia |
3.7% |
| Mantle Cell Lymphoma |
3.7% |
| Sleep Disorder Therapy |
3.7% |
| Depression |
2.5% |
| Dizziness |
2.5% |
| Dysmenorrhoea |
2.5% |
| Haemorrhoids |
2.5% |
| Antiretroviral Therapy |
1.2% |
| Back Pain |
1.2% |
| Bacterial Prostatitis |
1.2% |
| Blood Cholesterol Increased |
1.2% |
|
| Drug Interaction |
17.2% |
| Thrombosis In Device |
10.3% |
| Vomiting |
10.3% |
| Toxicity To Various Agents |
6.9% |
| Dyspepsia |
3.4% |
| Haemorrhage |
3.4% |
| Hallucination |
3.4% |
| Hepatotoxicity |
3.4% |
| Loss Of Consciousness |
3.4% |
| Muscle Haemorrhage |
3.4% |
| Off Label Use |
3.4% |
| Pitted Keratolysis |
3.4% |
| Potentiating Drug Interaction |
3.4% |
| Serotonin Syndrome |
3.4% |
| Skin Hyperpigmentation |
3.4% |
| Somnolence |
3.4% |
| Suicide Attempt |
3.4% |
| Torticollis |
3.4% |
| Upper Gastrointestinal Haemorrhage |
3.4% |
| Urine Output Decreased |
3.4% |
|
